Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Absorption (Phase 1)
Alzheimer Disease (Phase 1)
Amyotrophic Lateral Sclerosis (Phase 2)
Astrocytoma (Phase 1)
Ataxia (Phase 1)
Bipolar Disorder (Phase 2)
Blood (Phase 1)
Breast Neoplasms (Phase 1)
Burns (Phase 1)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Cardiomyopathy, Dilated (Phase 4)
Cardiovascular Diseases (Phase 4)
Charcot-Marie-Tooth Disease (Phase 1/Phase 2)
Coronary Artery Disease (Phase 3)
Coronary Stenosis (Phase 3)
Death, Sudden, Cardiac (Phase 2)
Depression (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 2)
Drugs, Investigational (Phase 4)
Dyslipidemias (Phase 3)
Fatigue Syndrome, Chronic (Phase 2/Phase 3)
Glaucoma, Open-Angle (Phase 1)
Glioblastoma (Phase 1)
Gliosarcoma (Phase 1)
Healthy Volunteers (Phase 4)
Heart Arrest (Phase 2)
Heart Failure (Phase 1)
Huntington Disease (Phase 3)
Hypertension (Phase 1)
Hypertension, Pulmonary (Phase 1)
Infertility (Phase 4)
Kidney Failure, Chronic (Phase 4)
Metabolic Syndrome (Phase 4)
Metabolism (Phase 4)
Mitochondrial Diseases (Phase 3)
Muscle Cramp (Phase 2/Phase 3)
Muscle Weakness (Phase 4)
Muscular Dystrophies, Limb-Girdle (Phase 2/Phase 3)
Muscular Dystrophy, Duchenne (Phase 3)
Myalgia (Phase 4)
Myelodysplastic Syndromes (Phase 2/Phase 3)
Neoplasms (Phase 1)
Nervous System Diseases (Phase 2/Phase 3)
Osteoporosis (Phase 2)
Pain (Phase 2/Phase 3)
Parkinson Disease (Phase 3)
Pre-Eclampsia (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Quality of Life (Phase 1/Phase 2)
Renal Dialysis (Phase 4)
Sleep Apnea Syndromes (Early Phase 1)
Spinal Cord Injuries (Phase 2)
Supranuclear Palsy, Progressive (Phase 2/Phase 3)
Vascular Calcification (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue